National Science Foundation

The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

James Donlon

Program Director

Debasis Majumdar

Program Director

Graciela Narcho

Staff Associate

Sethuraman Panchanathan

Director

Past deals in Wearables

IntelliSafe Analytics

Grant in 2023
IntelliSafe Analytics is the first company in the world to use wearable technology to obtain physiological and behavioral data from workers utilizing the human bodies built-in abilities to sense and respond to hazards. This data provides the engine for Artificial Intelligence models to identify hazards in the workplace and provide inputs that are used to predict and prevent accidents. The product is game-changing and will revolutionize the way workplace safety is conducted by addressing the human-factor related causes. IntelliSafe Analytics focuses on the worker, not the worker’s environment.

Samay

Grant in 2023
Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

NeuroGeneces

Grant in 2023
NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

Sharper Sense

Grant in 2022
Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.

Senseer

Grant in 2022
Senseer Health, founded in 2017, focuses on addressing the chronic disease market by developing Smart Medical Device Therapies for managing various chronic conditions, which affect a significant portion of older adults. The company's innovations began with patented microsensors that monitor implantable devices for patients with hydrocephalus, renal, and cardiovascular diseases. To enhance the effectiveness of these microsensor-enabled devices, Senseer has incorporated advanced wearable and ambient sensor technologies. The integration of these multi-modal sensor technologies with an IoT software platform allows for the utilization of proprietary data sets and predictive analytics. This comprehensive approach provides healthcare providers with tools for remote monitoring and timely interventions, ultimately aiming to improve the quality of life for individuals with chronic conditions while reducing costs and enhancing patient safety.

Claria Medical

Grant in 2022
Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

NeuroGeneces

Grant in 2022
NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

Evolution Devices

Grant in 2022
Evolution Devices, Inc. is a neuro rehabilitation technology company based in Berkeley, California, focused on enhancing mobility for individuals with neurological impairments. The company’s flagship product, EvoWalk, is a bio-electronic wearable device that utilizes functional electrical stimulation and artificial intelligence to track walking patterns and personalize rehabilitation therapy. EvoWalk is designed for patients recovering from conditions such as stroke, multiple sclerosis, ALS, cerebral palsy, traumatic brain injury, and incomplete spinal cord injury. The device employs sensors that deliver electrical stimulation to leg muscles and the peroneal nerve, aiding in foot elevation during walking. This technology aims to eliminate foot drop, reduce fatigue, and minimize the risk of tripping accidents. Evolution Devices, formerly known as Foot++, Inc., was established in 2017 and rebranded in September 2019.

Samay

Grant in 2022
Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

JelikaLite

Grant in 2022
JelikaLite specializes in developing medical equipment for children with autism spectrum disorders, focusing on non-invasive methods to enhance brain health. Their primary product is a wearable device that integrates infrared light, EEG sensors, and an artificial intelligence personalization platform. This therapeutic device aims to reduce the symptoms of autism by promoting improvements in speech, decreasing anxiety, and enhancing responsiveness in pediatric patients. By utilizing innovative therapies, JelikaLite seeks to provide lasting benefits for children dealing with autism, emphasizing a commitment to advancing pediatric neurological health.

Strados Labs

Grant in 2022
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

Lura Health

Grant in 2022
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

UCHU Biosensors

Grant in 2022
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Mesodyne

Grant in 2022
Mesodyne is an engineering and manufacturing company focused on innovative electricity generation solutions, particularly through its patented LightCell technology, which converts various fuels into electricity using light. Founded in 2018 by Drs. Veronika Stelmakh and Walker Chan, the company aims to deliver portable and reliable power generation systems to military and commercial users. Mesodyne's compact power generators enhance the endurance of small autonomous systems, offering efficient and long-lasting energy sources that bridge the gap between traditional batteries and internal combustion engines. This technology is designed to alleviate the burden on dismounted warfighters and emergency responders while extending the operational range of unmanned vehicles, wearables, and other equipment.

Xplosion Technology

Grant in 2022
A Personal Coaching Assistant, Xplosion is a 4D Motion Baseball Training system that is Providing a range of sensors that you can put on the Body and Sporting Equipment.

CereVu Medical

Grant in 2021
CereVu Medical focuses on enhancing patient care through an advanced pain management system. Their innovative solution features a small, wearable, single-use patch that adheres to a patient’s forehead, linking to a reusable monitoring console. This system employs proprietary algorithms and signal processing techniques to analyze personalized cerebral hemodynamic information. By doing so, it allows physicians to continuously assess a patient's pain levels and monitor the effectiveness of prescribed treatments, ensuring that care is tailored to individual patient needs.

OsciFlex

Grant in 2021
OsciFlex LLC, founded in 2017 and based in Philadelphia, Pennsylvania, specializes in developing a wearable medical device aimed at preventing blood clots in patients. The device functions by stimulating calf muscle contractions through a muscle stretch reflex, which promotes valve sinus recirculatory flow. This innovative approach helps to prevent venous thromboembolism (VTE), a serious condition that can lead to significant health complications. By offering an alternative to traditional anti-coagulation pharmaceuticals, which can be costly and carry risks, OsciFlex aims to enhance patient care and reduce healthcare costs associated with blood clot management.

QuadraLynx

Grant in 2021
Quadralynx specializes in the development of wearable biometric devices tailored for adults experiencing motor speech disorders, particularly those who face challenges with volume control due to Parkinson's disease and similar neurological conditions. The company's innovative device employs biofeedback technology to alert users through vibrations when their voice reaches a pathological state. By focusing on speech and voice improvement, Quadralynx aims to enhance the quality of life for individuals affected by these disorders.

Echowear

Grant in 2021
Echowear is a company focused on enhancing healthcare access through an innovative smartwatch-based system. This system is designed to facilitate meaningful interactions between patients and care teams, ultimately creating actionable digital health services. Echowear's approach aims to provide users with age-friendly health technologies, allowing for a more inclusive and effective healthcare experience. By leveraging digital solutions, the company seeks to improve patient engagement and streamline communication within the healthcare ecosystem.

Organic Robotics

Grant in 2021
Organic Robotics Corporation, founded in 2018 and based in Rochester, New York, specializes in the design and development of advanced sensors that measure touch in real time. The company's flagship product, Light Lace, utilizes fiber-optic technology to create a flexible sensor capable of bending and twisting with the human body, offering effective motion capture and pressure sensing. This innovative solution combines sensibility, elasticity, and washability at a competitive cost. Additionally, Organic Robotics focuses on performance monitoring for professional athletes, providing real-time feedback on motion, muscle fatigue, and vital signs. Their technology is designed for comfort and minimal distraction, enabling accurate analysis of chest movement to deliver actionable insights regarding fatigue and performance levels.

Ranial Systems

Grant in 2021
Ranial Systems develops a real-time process automation platform that integrates cognitive artificial intelligence with edge computing. The platform is tailored for various sectors, specifically targeting smart energy, real-time plant monitoring, and automation in wearable technology. Additionally, the company explores emerging opportunities in context-aware business process automation and provides advisory services related to product development and co-innovation. By focusing on these areas, Ranial Systems aims to assist the manufacturing and healthcare industries in addressing significant challenges within the business process automation landscape.

Clairways

Grant in 2021
Clairways specializes in smart lung monitoring technology designed for pharmaceutical clinical trials. The company develops a wearable digital lung monitor that captures critical respiratory metrics for individuals suffering from conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Fitted to the body, this device employs acoustic sensors and machine learning technology to detect and characterize various respiratory metrics. The collected data is presented in an accessible format, allowing healthcare providers to easily monitor and assess patients' respiratory health over the long term.

NanoPattern Technologies

Grant in 2021
NanoPattern Technologies, established in 2019 and based in Chicago, Illinois, specializes in the development of photopatternable quantum dot formulations aimed at advancing display technologies. The company focuses on creating nanoparticle inks specifically designed for Quantum Dot-MicroLED and quantum dot-organic light-emitting diode display systems. Their patented resin-free nanoparticle lithography technology facilitates the high-resolution patterning of quantum dot downconverter layers. This innovation is intended to enhance the performance of display systems used in a variety of applications, including televisions, smartphones, wearables, and augmented and virtual reality devices.

Empo Health

Grant in 2021
Empo Health specializes in in-home health monitoring solutions that enhance patient care by integrating seamlessly into daily life. The company has developed an innovative imaging bathroom scale and a digital health platform aimed at detecting early signs of diabetic foot conditions, thereby helping to prevent amputations. By providing reliable visual data outside of clinical settings, Empo Health enables both patients and clinicians to monitor health effectively and maintain standards of care. Through its advanced technology, the company seeks to improve health outcomes and foster proactive management of chronic conditions.

Samay

Grant in 2021
Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Innsightful

Grant in 2021
Innsightful offers a comprehensive digital health solution aimed at managing and alleviating mental health challenges, particularly for students. The company develops wearable devices that monitor and detect symptoms of anxiety and stress, utilizing artificial intelligence and machine learning to provide automated, early detection of heightened stress levels. These devices integrate biometrics to give users personalized insights, fostering a deeper understanding of their mental health. Additionally, Innsightful facilitates access to therapists for tailored recommendations and progress assessments, transforming how individuals approach their mental well-being.

LumenAstra

Grant in 2021
LumenAstra, founded in 2020 and headquartered in Longmont, Colorado, develops non-invasive, wearable deep-tissue temperature sensors aimed at enhancing patient care in various medical contexts. The company's innovative technology allows for the external measurement of internal temperature, making it particularly useful in cancer hyperthermia therapy. Additionally, LumenAstra's sensors have applications in monitoring hypothermia during aortic dissection repair, brain temperature in neonatal hypoxia-ischemia cases, and internal heat stress in military and hazardous environments. This technology enables medical professionals to effectively protect patients from serious injuries and fatalities related to heat stress.

JuneBrain

Grant in 2021
JuneBrain, LLC is a Washington, D.C.-based company founded in 2017 that focuses on developing wearable and non-invasive imaging devices for multiple sclerosis patients. The technology allows patients to monitor their disease activity from home, facilitating earlier detection of MS attacks and enhancing the monitoring of treatment efficacy. By leveraging telemedicine, JuneBrain aims to optimize remote assessment for neurological diseases, thereby enabling clinicians to track patients outside traditional clinical settings. The company's long-term vision includes extending its device's applications to a broader range of neurodegenerative diseases, promoting more accessible and frequent monitoring of brain health.

Notus Labs

Grant in 2021
Notus Labs specializes in developing wearable devices that enable individuals to monitor their health and performance in a remote and non-invasive manner. These devices provide a continuous and comprehensive summary of vital signs, which can help optimize medical triaging during instances of sudden physiological deterioration. By utilizing Notus Labs' technology, users can effectively mitigate the risks associated with overexertion injuries and heat-related illnesses. Additionally, the devices offer training suggestions to enhance physical performance, allowing users to maximize their growth while maintaining safety during physical activities.

Lightengale

Grant in 2021
Lightengale is a developer of medical devices focused on enhancing safety in healthcare settings, particularly in intensive care units. The company has created an innovative infusion line that utilizes light-emitting cables to illuminate individual intravenous (IV) lines from the pump to the patient. This design addresses the critical issue of line mix-ups and medication delivery errors, which can pose significant risks to patient safety. By providing visual cues for nurses to accurately trace IV lines, Lightengale's technology allows healthcare professionals to dedicate more time to patient care, ultimately improving the overall quality of medical treatment.

Alva Health

Grant in 2021
Alva Health specializes in the development of healthcare wearables focused on remote stroke monitoring. The company's patented devices operate continuously to detect stroke signatures, specifically identifying the onset of hemiparesis, or paralysis on one side of the body. By connecting users to emergency services, Alva Health's technology aims to empower older adults at high risk of stroke, facilitating early intervention to prevent disability. The company is committed to transforming stroke treatment and advancing neurotechnologies that enhance patient safety and independence, ultimately providing peace of mind for families.

Cogwear

Grant in 2021
Cogwear is a brain technology company focused on addressing the needs of individuals suffering from anxiety and depression. The firm is developing a next-generation wearable device that enhances traditional physical measurements by integrating cognitive and emotional insights. This innovation aims to transition brain monitoring from laboratory settings to everyday life, providing users with real-time access to clinical-grade cognitive and emotional data. Utilizing AI-powered algorithms and proprietary dry electroencephalography (EEG) sensors, the wearable comfortably and accurately measures brain activity. The device captures and analyzes brainwaves, enabling users to receive feedback on their mental state through a secure app and shareable dashboard. By unlocking valuable insights into brain health, Cogwear aspires to improve individual well-being and performance.

SweatID

Grant in 2021
SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Rhaeos

Grant in 2021
Rhaeos is a pioneering company that has developed the first wearable shunt monitor to enhance care for patients with hydrocephalus. Utilizing a novel thermal biosensor, the device allows for noninvasive, real-time monitoring of cerebrospinal fluid flow. This innovative technology, born from collaborative research at Northwestern University involving experts from engineering, medicine, and management, addresses a significant clinical need by providing timely data to improve treatment for chronic medical conditions. Rhaeos's patches are designed to detect fluid flow in various bodily systems, including blood and lymph, facilitating quicker medical responses and advancing the standard of care in neurosurgery and beyond.

Vena Vitals

Grant in 2021
Vena Vitals is a company that develops a small wearable device designed for continuous blood pressure monitoring. This innovative technology has shown accuracy comparable to invasive arterial lines in clinical settings such as operating rooms and intensive care units. By focusing on applications in the healthcare sector, Vena Vitals aims to enhance the management and monitoring of blood pressure, which is crucial for individuals with hypertension and other cardiovascular conditions. The company's platform has the potential to significantly improve the quality of care provided to patients, making it a valuable asset in clinical environments where blood pressure data is essential.

Nextiles

Grant in 2021
Nextiles is a New York-based company founded in 2019 that specializes in smart apparel technology, merging athletic clothing with an advanced analytics system to enhance exercise performance and safety. The company innovatively integrates electrically conductive fibers into fabrics using a patented sewing technology, allowing for the development of wearables that include motion sensors directly within the apparel. This unique approach enables the creation of responsive and adaptive devices, providing valuable insights into an individual's movement patterns. With a strong foundation in electrical engineering and circuit design, Nextiles offers its expertise to businesses looking to develop or enhance their own Internet of Things (IoT) and smart device products.

NanoInnovations

Grant in 2020
NanoInnovations is a research and development company established in 2014 and based in Sugar Land, Texas. It focuses on the commercialization of smart nanosensors integrated with machine learning technologies for healthcare analytics. The company's innovative platform utilizes bio-fluids, including sweat and saliva, to provide valuable insights for managing conditions such as diabetes and heart failure. By delivering real-time information, NanoInnovations aims to enhance patient care and improve healthcare management, empowering clients to make informed decisions in their medical practices.

Claria Medical

Grant in 2020
Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

HabitAware

Grant in 2020
HabitAware, Inc. is a company that develops and sells wearable devices aimed at helping individuals manage subconscious behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. Its flagship product, Liv, is a smart awareness bracelet equipped with motion sensors that alerts users when they engage in these habits. The accompanying Liv application provides training to help users recognize their problematic behaviors, track their progress, identify triggers, and offers strategies for replacing these habits with healthier alternatives. Founded in 2014 and headquartered in Minneapolis, Minnesota, HabitAware focuses on supporting both children and adults in gaining control over their compulsive behaviors. The company sells its products online, making its resources accessible to a wide audience.

Intake Health

Grant in 2020
Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

Marani

Grant in 2020
Marani Health is focused on advancing prenatal care through the development of a wearable, textile-based technology that monitors key vital statistics for women and their developing fetuses during pregnancy, labor, and delivery. By leveraging artificial intelligence, Marani's product provides timely and accurate data, enhancing the assessment of maternal and fetal health. The company collaborates with prominent partners, including The Mayo Clinic, to improve health outcomes for mothers and their babies.

Behaivior

Grant in 2020
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

Lura Health

Grant in 2020
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

CereVu Medical

Grant in 2020
CereVu Medical focuses on enhancing patient care through an advanced pain management system. Their innovative solution features a small, wearable, single-use patch that adheres to a patient’s forehead, linking to a reusable monitoring console. This system employs proprietary algorithms and signal processing techniques to analyze personalized cerebral hemodynamic information. By doing so, it allows physicians to continuously assess a patient's pain levels and monitor the effectiveness of prescribed treatments, ensuring that care is tailored to individual patient needs.

Kinetic

Grant in 2020
Kinetic, Inc. is a company that develops and manufactures wearable devices aimed at reducing workplace injuries for industrial workers. Founded in 2014 and based in New York, Kinetic offers a product known as Reflex, which attaches to a worker's belt and monitors activities that may pose a risk of injury, such as unsafe postures, jumping off vehicles, and slips and falls. The device utilizes analytics to provide reminders and notifications to workers when high-risk motions are detected, thereby promoting safety in environments like construction sites, warehouses, and factories. Additionally, Reflex can function as a sensor for detecting COVID-19 exposure, enhancing workplace health measures. Kinetic combines its wearable technology with cloud-based software to effectively address injury prevention in the industrial workforce.

UCHU Biosensors

Grant in 2020
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Koya Medical

Grant in 2020
Koya Medical, Inc., founded in 2018 and based in Oakland, California, specializes in developing innovative therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. The company focuses on creating wearable technology that delivers active compression therapy, which is designed to enhance movement and mobility for patients. Koya Medical's approach offers a personalized alternative to traditional compression methods, utilizing a sensor-based closed-loop system to provide tailored compression patterns. This technology addresses the needs of patients suffering from conditions such as lymphedema, chronic edema, and chronic venous insufficiency, thereby improving their quality of care and overall treatment outcomes.

Strados Labs

Grant in 2020
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

Ateios

Grant in 2020
Ateios Inc. develops advanced technology for manufacturing ultra-thin and customizable batteries suitable for various applications in electronics. Based in Indianapolis, Indiana, the company was founded in 2018 and focuses on creating zinc-oxide batteries that offer 2-5 times higher energy density compared to traditional coin cells. This innovative manufacturing process enables the production of flexible batteries that can be tailored to fit specific product requirements. Ateios' technology is particularly applicable to smart textiles, soft robotics, Internet-of-Things (IoT) devices, and medical or fitness wearables. By facilitating a new generation of thin and flexible electronics, Ateios aims to enhance the integration of battery technology into diverse electronic devices.

Organic Robotics

Grant in 2020
Organic Robotics Corporation, founded in 2018 and based in Rochester, New York, specializes in the design and development of advanced sensors that measure touch in real time. The company's flagship product, Light Lace, utilizes fiber-optic technology to create a flexible sensor capable of bending and twisting with the human body, offering effective motion capture and pressure sensing. This innovative solution combines sensibility, elasticity, and washability at a competitive cost. Additionally, Organic Robotics focuses on performance monitoring for professional athletes, providing real-time feedback on motion, muscle fatigue, and vital signs. Their technology is designed for comfort and minimal distraction, enabling accurate analysis of chest movement to deliver actionable insights regarding fatigue and performance levels.

Manus Robotics

Grant in 2020
Manus Robotics is focused on developing a smart health and wellness device aimed at promoting independent and healthy living. The company offers a wearable robot that assists individuals with disabilities in their daily activities, providing intelligent support to enhance their quality of life. In addition to daily living assistance, the device collects and analyzes muscle data from patients, facilitating rehabilitation efforts and helping users regain independence.

Samay

Grant in 2020
Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Evolution Devices

Grant in 2020
Evolution Devices, Inc. is a neuro rehabilitation technology company based in Berkeley, California, focused on enhancing mobility for individuals with neurological impairments. The company’s flagship product, EvoWalk, is a bio-electronic wearable device that utilizes functional electrical stimulation and artificial intelligence to track walking patterns and personalize rehabilitation therapy. EvoWalk is designed for patients recovering from conditions such as stroke, multiple sclerosis, ALS, cerebral palsy, traumatic brain injury, and incomplete spinal cord injury. The device employs sensors that deliver electrical stimulation to leg muscles and the peroneal nerve, aiding in foot elevation during walking. This technology aims to eliminate foot drop, reduce fatigue, and minimize the risk of tripping accidents. Evolution Devices, formerly known as Foot++, Inc., was established in 2017 and rebranded in September 2019.

Shade

Grant in 2020
Shade is a New York-based company that designs and develops advanced wearable ultraviolet measuring technology aimed at patients with lupus, skin cancer, and diabetes. Its primary product, an ultra-sensitive wearable UV sensor, provides real-time and accurate measurements of UV exposure based on clinical evidence. The sensor is designed to determine the daily threshold of UV exposure relevant to dermatological care, particularly for photosensitive diseases. By delivering timely notifications, the device empowers patients to make informed decisions about sun exposure, helping them manage their health effectively. Shade's development has received support from the National Cancer Institute and the National Science Foundation, underscoring its commitment to enhancing patient care through innovative technology.

Multisensor Diagnostics

Grant in 2020
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

Bitome

Grant in 2020
Bitome is a Boston-based company specializing in connected medical devices, focusing on noninvasive hydration monitoring technology. Established two years ago, Bitome's first product is designed to monitor hydration status, with significant applications in fields such as dialysis, diabetes management, sports performance, and maternal/fetal health. One of its primary uses is in assessing volume status in patients with congestive heart failure (CHF), a critical but challenging biometric to measure that is closely linked to patient outcomes. By enhancing hydration monitoring, Bitome aims to revolutionize CHF management in a manner similar to how glucose monitoring transformed diabetes care.

Globe Biomedical

Grant in 2020
Globe Biomedical, established in 2017 and based in Riverside, California, specializes in developing wearable technology for glaucoma patients. Their core product is an ocular healthcare device, discreetly integrated into eyeglass frames, which wirelessly transmits data on eye health, enabling patients and healthcare providers to monitor and manage glaucoma more effectively.

XOnano Smartfoam

Grant in 2019
XOnano's aim is to ensure the highest grade foam padding available. When standard foam is replaced with Xonano Smartfoam one can receive real-time feedback in anything from helmets to body armor. Not only does Xonano Smartfoam provide real-time feedback but it provides an extra level of protection.

HabitAware

Grant in 2019
HabitAware, Inc. is a company that develops and sells wearable devices aimed at helping individuals manage subconscious behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. Its flagship product, Liv, is a smart awareness bracelet equipped with motion sensors that alerts users when they engage in these habits. The accompanying Liv application provides training to help users recognize their problematic behaviors, track their progress, identify triggers, and offers strategies for replacing these habits with healthier alternatives. Founded in 2014 and headquartered in Minneapolis, Minnesota, HabitAware focuses on supporting both children and adults in gaining control over their compulsive behaviors. The company sells its products online, making its resources accessible to a wide audience.

Rhaeos

Grant in 2019
Rhaeos is a pioneering company that has developed the first wearable shunt monitor to enhance care for patients with hydrocephalus. Utilizing a novel thermal biosensor, the device allows for noninvasive, real-time monitoring of cerebrospinal fluid flow. This innovative technology, born from collaborative research at Northwestern University involving experts from engineering, medicine, and management, addresses a significant clinical need by providing timely data to improve treatment for chronic medical conditions. Rhaeos's patches are designed to detect fluid flow in various bodily systems, including blood and lymph, facilitating quicker medical responses and advancing the standard of care in neurosurgery and beyond.

SlateSafety

Grant in 2019
SlateSafety develops a real-time physiological monitoring platform aimed at enhancing situational awareness and ensuring team safety in demanding work environments. The company's system focuses on injury prevention by utilizing a wearable safety device that monitors and collects physiological data from group members. This data is then accessible to authorized personnel through a web interface, allowing for real-time monitoring and post-incident analysis. By providing actionable insights, SlateSafety's platform helps users avoid overexertion injuries while performing strenuous tasks, ultimately fostering a safer workplace for large teams.

NanoPattern Technologies

Grant in 2019
NanoPattern Technologies, established in 2019 and based in Chicago, Illinois, specializes in the development of photopatternable quantum dot formulations aimed at advancing display technologies. The company focuses on creating nanoparticle inks specifically designed for Quantum Dot-MicroLED and quantum dot-organic light-emitting diode display systems. Their patented resin-free nanoparticle lithography technology facilitates the high-resolution patterning of quantum dot downconverter layers. This innovation is intended to enhance the performance of display systems used in a variety of applications, including televisions, smartphones, wearables, and augmented and virtual reality devices.

unspun

Grant in 2019
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Pison

Grant in 2019
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, and improving overall quality of life.

Alva Health

Grant in 2019
Alva Health specializes in the development of healthcare wearables focused on remote stroke monitoring. The company's patented devices operate continuously to detect stroke signatures, specifically identifying the onset of hemiparesis, or paralysis on one side of the body. By connecting users to emergency services, Alva Health's technology aims to empower older adults at high risk of stroke, facilitating early intervention to prevent disability. The company is committed to transforming stroke treatment and advancing neurotechnologies that enhance patient safety and independence, ultimately providing peace of mind for families.

Biosenix

Grant in 2019
Biosenix is a medical technology company that develops wearable medical devices for monitoring the health of the elderly. The company was founded in 2018 in Tucson, Arizona.

Pneumico

Grant in 2019
Pneumico is a company based in Baltimore, Maryland, established in 2017, that specializes in developing respiratory monitoring devices designed for patients requiring ventilatory assistance. The company's innovative device utilizes a compact electronic monitor that can be attached to any bag valve mask. This technology enables the collection, analysis, and presentation of breathing data, which is essential for enhancing assistive breathing methods and workflows. By providing real-time data, Pneumico's solutions aim to improve ventilation safety and effectiveness, ultimately leading to better health outcomes for patients with respiratory challenges.

Senseer

Grant in 2019
Senseer Health, founded in 2017, focuses on addressing the chronic disease market by developing Smart Medical Device Therapies for managing various chronic conditions, which affect a significant portion of older adults. The company's innovations began with patented microsensors that monitor implantable devices for patients with hydrocephalus, renal, and cardiovascular diseases. To enhance the effectiveness of these microsensor-enabled devices, Senseer has incorporated advanced wearable and ambient sensor technologies. The integration of these multi-modal sensor technologies with an IoT software platform allows for the utilization of proprietary data sets and predictive analytics. This comprehensive approach provides healthcare providers with tools for remote monitoring and timely interventions, ultimately aiming to improve the quality of life for individuals with chronic conditions while reducing costs and enhancing patient safety.

HeroWear

Grant in 2019
HeroWear is a company focused on developing innovative wearable technology designed to enhance worker safety, health, and productivity in physically demanding roles. Their flagship product, the Apex, is a back-assist exosuit specifically engineered for both men and women. This garment aims to alleviate back strain and fatigue while maintaining the comfort of everyday clothing. The Apex incorporates patent-pending dual-mode technology, which allows users to easily toggle back support on and off, making it versatile for various work environments. Additionally, the exosuit's modular textile design offers over 50 customizable combinations, ensuring that it can be tailored to fit the specific needs of any worker engaged in strenuous tasks. Through these advancements, HeroWear aims to reduce physical strain and improve the overall well-being of employees in demanding jobs.

ThermoBionics

Grant in 2019
ThermoBionics specializes in the production of wearable cooling goods that leverage innovative technology to enhance cooling efficiency while reducing weight. The company's proprietary, patent-pending technology effectively manages the body's thermoregulatory functions, allowing users to minimize sweating and facilitate moisture evaporation, regardless of external temperature and humidity conditions. This advancement provides a practical solution for individuals seeking comfort in varying environmental conditions.

Intake Health

Grant in 2019
Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

Litterati

Grant in 2019
Litterati is an application designed to promote environmental cleanliness by encouraging users to pick up and track litter. The app allows users to capture images of litter, which are automatically geo-tagged and categorized, providing valuable data on litter types. Litterati aims to foster community involvement by enabling groups such as schools and clubs to track their collective litter collection efforts. Additionally, the app plans to incorporate mapping features, allowing users to see litter-clearing activities within their neighborhoods. Through these initiatives, Litterati seeks to unite individuals, organizations, and governments in creating cleaner streets and communities.

Ares Materials

Grant in 2019
Ares Materials, Inc. specializes in the development of flexible electronics for various personal devices and applications. The company offers solutions for electrophoretic displays, wearable displays, rollable electronics, smart packaging, and architectural electronics, among others. Ares Materials employs an innovative chemistry platform and artificial intelligence to create customized substrates and novel optical thiol-based polymers, facilitating the advancement of flexible electronics. Its technology enables the fabrication of thin film transistors and supports the commercialization of next-generation electronic products. Founded in 2014, Ares Materials is headquartered in Dallas, Texas, and is committed to addressing the emerging needs of the display industry through its cutting-edge materials and technologies.

QLEDCures

Grant in 2019
QLEDCures is a medical technology company developing quantum dot light-emitting devices (QLEDs) for light-based medical treatments. Their innovative QLEDs aim to replace expensive and bulky lasers and LED systems with wearable, flexible devices, enabling new treatment options and expanding access to photobiomodulation and photodynamic therapy.

Globe Biomedical

Grant in 2019
Globe Biomedical, established in 2017 and based in Riverside, California, specializes in developing wearable technology for glaucoma patients. Their core product is an ocular healthcare device, discreetly integrated into eyeglass frames, which wirelessly transmits data on eye health, enabling patients and healthcare providers to monitor and manage glaucoma more effectively.

SweatID

Grant in 2019
SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Clairways

Grant in 2019
Clairways specializes in smart lung monitoring technology designed for pharmaceutical clinical trials. The company develops a wearable digital lung monitor that captures critical respiratory metrics for individuals suffering from conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Fitted to the body, this device employs acoustic sensors and machine learning technology to detect and characterize various respiratory metrics. The collected data is presented in an accessible format, allowing healthcare providers to easily monitor and assess patients' respiratory health over the long term.

OsciFlex

Grant in 2019
OsciFlex LLC, founded in 2017 and based in Philadelphia, Pennsylvania, specializes in developing a wearable medical device aimed at preventing blood clots in patients. The device functions by stimulating calf muscle contractions through a muscle stretch reflex, which promotes valve sinus recirculatory flow. This innovative approach helps to prevent venous thromboembolism (VTE), a serious condition that can lead to significant health complications. By offering an alternative to traditional anti-coagulation pharmaceuticals, which can be costly and carry risks, OsciFlex aims to enhance patient care and reduce healthcare costs associated with blood clot management.

Embr Labs

Grant in 2018
Embr Labs Inc. is a company based in Somerville, Massachusetts, that specializes in developing thermal comfort devices aimed at enhancing human well-being. Founded in 2014 and originally known as Wristify Inc., Embr Labs has created innovative technology that uses temperature to influence the autonomic nervous system, helping users manage conditions such as hot flashes, sleep disturbances, and anxiety. The company's wearable devices, combined with a mobile app and cloud infrastructure, provide a unique platform for thermal stimulation and digital interventions, allowing users to track and manage their symptoms effectively. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology originated from the founders' work as engineering students at MIT and has received significant backing from investors and over $2.5 million in grants from various organizations.

unspun

Grant in 2018
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Behaivior

Grant in 2018
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

SABER

Grant in 2018
SABER Corporation is focused on developing an innovative antimicrobial bandage designed to enhance infection control in healthcare settings. This programmable bandage utilizes blue light in the wavelength range of 400-470nm to prevent bacterial contamination on postoperative incisions and wound sites, thereby reducing the incidence of surgical site infections (SSIs). The bandage effectively inactivates a wide array of clinical pathogens, including those resistant to antibiotics, without harming mammalian cells or promoting bacterial resistance. Its unique design features a thin, transparent, multilayer thermally managed LED sheet that automates disinfection and provides real-time performance data, facilitating improved accountability for hospital staff. This wearable device integrates seamlessly into existing infection prevention protocols, offering a cost-saving solution while promoting better wound healing and maintaining low bacterial counts in wounds. SABER's approach represents a significant advancement in the field of infection control.

Tanzen Medical

Grant in 2018
Tanzen Medical, founded in 2017 and located in Severna Park, Maryland, specializes in the development of clinically accurate wearable devices aimed at assessing and enhancing sleep quality in a home setting. The company's innovative technology is designed to aid in the diagnosis of sleep-related disorders, such as ADHD and narcolepsy, by monitoring nightly leg movements. This functionality allows users to track various aspects of their sleep, including quality, position, and arousal, ultimately promoting better sleep health.

Samay

Grant in 2018
Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

JuneBrain

Grant in 2018
JuneBrain, LLC is a Washington, D.C.-based company founded in 2017 that focuses on developing wearable and non-invasive imaging devices for multiple sclerosis patients. The technology allows patients to monitor their disease activity from home, facilitating earlier detection of MS attacks and enhancing the monitoring of treatment efficacy. By leveraging telemedicine, JuneBrain aims to optimize remote assessment for neurological diseases, thereby enabling clinicians to track patients outside traditional clinical settings. The company's long-term vision includes extending its device's applications to a broader range of neurodegenerative diseases, promoting more accessible and frequent monitoring of brain health.

Therapeutic Innovations

Grant in 2018
Therapeutic Innovations focuses on creating low-cost medical devices aimed at treating pediatric diseases, particularly in emerging economies. The company specializes in wearable orthopedic devices designed to address various injuries, as well as developing innovative solutions for respiratory issues in newborns, including the bCPAP device branded as Airbaby. By prioritizing affordability without sacrificing quality, Therapeutic Innovations aims to ensure that all children worldwide have equitable access to essential medical interventions. This commitment to improving healthcare for children positions the company as a key player in the medical device industry, particularly in addressing the pressing needs of vulnerable populations.

SlateSafety

Grant in 2018
SlateSafety develops a real-time physiological monitoring platform aimed at enhancing situational awareness and ensuring team safety in demanding work environments. The company's system focuses on injury prevention by utilizing a wearable safety device that monitors and collects physiological data from group members. This data is then accessible to authorized personnel through a web interface, allowing for real-time monitoring and post-incident analysis. By providing actionable insights, SlateSafety's platform helps users avoid overexertion injuries while performing strenuous tasks, ultimately fostering a safer workplace for large teams.

Mesodyne

Grant in 2018
Mesodyne is an engineering and manufacturing company focused on innovative electricity generation solutions, particularly through its patented LightCell technology, which converts various fuels into electricity using light. Founded in 2018 by Drs. Veronika Stelmakh and Walker Chan, the company aims to deliver portable and reliable power generation systems to military and commercial users. Mesodyne's compact power generators enhance the endurance of small autonomous systems, offering efficient and long-lasting energy sources that bridge the gap between traditional batteries and internal combustion engines. This technology is designed to alleviate the burden on dismounted warfighters and emergency responders while extending the operational range of unmanned vehicles, wearables, and other equipment.

Litterati

Grant in 2018
Litterati is an application designed to promote environmental cleanliness by encouraging users to pick up and track litter. The app allows users to capture images of litter, which are automatically geo-tagged and categorized, providing valuable data on litter types. Litterati aims to foster community involvement by enabling groups such as schools and clubs to track their collective litter collection efforts. Additionally, the app plans to incorporate mapping features, allowing users to see litter-clearing activities within their neighborhoods. Through these initiatives, Litterati seeks to unite individuals, organizations, and governments in creating cleaner streets and communities.

Shade

Grant in 2017
Shade is a New York-based company that designs and develops advanced wearable ultraviolet measuring technology aimed at patients with lupus, skin cancer, and diabetes. Its primary product, an ultra-sensitive wearable UV sensor, provides real-time and accurate measurements of UV exposure based on clinical evidence. The sensor is designed to determine the daily threshold of UV exposure relevant to dermatological care, particularly for photosensitive diseases. By delivering timely notifications, the device empowers patients to make informed decisions about sun exposure, helping them manage their health effectively. Shade's development has received support from the National Cancer Institute and the National Science Foundation, underscoring its commitment to enhancing patient care through innovative technology.

Pison

Grant in 2017
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, and improving overall quality of life.

Blumio

Grant in 2017
Blumio, Inc. is a San Francisco-based company founded in 2014 that specializes in developing non-invasive wearable sensors for cardiovascular diagnostics, particularly blood pressure monitoring. The company’s innovative technology employs radio frequency to detect and analyze arterial tissue movements, allowing for continuous blood pressure measurement without the need for traditional inflatable cuffs. Blumio aims to address the limitations of conventional blood pressure monitoring methods, which typically rely on measurements taken at rest with a sphygmomanometer. By providing a portable sensor that can be integrated with everyday devices, such as an iPhone case, Blumio enables users to accurately track their blood pressure throughout daily activities, enhancing the understanding of cardiovascular health.

Aluna

Grant in 2017
Aluna, established in 2013 and headquartered in San Francisco, specializes in developing medical devices and digital health platforms for managing chronic respiratory conditions, primarily asthma. The company's core product is a portable spirometry device that connects with an interactive iPhone game, enabling users, especially children, to track and monitor their asthma symptoms, medication, and potential triggers in real-time. This data is shared with healthcare providers, facilitating personalized treatment plans and early intervention. Aluna's mission is to empower patients to understand and manage their lung health, improving overall asthma outcomes.

Mobile Sense Technologies

Grant in 2017
Mobile Sense Technologies, Inc. specializes in the development of wearable wireless sensor bands designed for cardiac monitoring. Its flagship product, SensBand, is a non-adhesive, wireless, and waterproof device that can be worn on the arm or wrist, allowing for continuous monitoring and automatic detection of dangerous heart arrhythmias. Founded in 2016 and based in Farmington, Connecticut, the company has leveraged over seven years of research and significant funding to create a platform that offers high-fidelity ECG and PPG recordings. This innovation transforms traditional diagnostic practices by providing real-time data and alerts to both patients and healthcare providers, facilitating long-term management of cardiac conditions. The wearables are designed to be used in various environments, ensuring that patients can maintain monitoring during activities such as running or swimming.

SIL Technologies

Grant in 2017
SIL Technologies creates wearable technology to prevent decompression sickness underwater. SIL Technologies has been conducting multiphase science research that results in innovative solutions for specific global needs since 2016.

Aira

Grant in 2017
Aira is dedicated to enhancing accessibility for individuals who are blind or have low vision. The company offers remote visual interpretation services through an app that connects users with highly trained Visual Interpreters. By streaming live video from the user's smartphone camera, these interpreters assist with a variety of tasks, including navigation and face recognition, enabling users to engage more fully in daily activities. Additionally, Aira has developed a wearable assistive product that utilizes smart glasses and an augmented reality dashboard, allowing certified agents to see what the user sees in real-time. This combination of technology and human support empowers visually impaired individuals to navigate their environments with greater independence and confidence.

Ares Materials

Grant in 2017
Ares Materials, Inc. specializes in the development of flexible electronics for various personal devices and applications. The company offers solutions for electrophoretic displays, wearable displays, rollable electronics, smart packaging, and architectural electronics, among others. Ares Materials employs an innovative chemistry platform and artificial intelligence to create customized substrates and novel optical thiol-based polymers, facilitating the advancement of flexible electronics. Its technology enables the fabrication of thin film transistors and supports the commercialization of next-generation electronic products. Founded in 2014, Ares Materials is headquartered in Dallas, Texas, and is committed to addressing the emerging needs of the display industry through its cutting-edge materials and technologies.

unspun

Grant in 2017
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Thalchemy

Grant in 2017
Thalchemy Corp., established in 2012 and based in Madison, Wisconsin, specializes in developing neurally-inspired algorithms and accelerators. These innovations mimic the mammalian thalamus' operation, enabling continuous sensory processing in battery-operated devices like smartphones. Thalchemy's technology extends battery life, facilitates power-optimized voice and gesture control, and allows for the creation of new always-on applications. It also offers a simplified development approach with an automated, zero-lines-of-code system. Additionally, Thalchemy's technology can be used in healthcare monitoring systems, detecting and alerting in case of falls or irregular heartbeats.

Kinetic

Grant in 2017
Kinetic, Inc. is a company that develops and manufactures wearable devices aimed at reducing workplace injuries for industrial workers. Founded in 2014 and based in New York, Kinetic offers a product known as Reflex, which attaches to a worker's belt and monitors activities that may pose a risk of injury, such as unsafe postures, jumping off vehicles, and slips and falls. The device utilizes analytics to provide reminders and notifications to workers when high-risk motions are detected, thereby promoting safety in environments like construction sites, warehouses, and factories. Additionally, Reflex can function as a sensor for detecting COVID-19 exposure, enhancing workplace health measures. Kinetic combines its wearable technology with cloud-based software to effectively address injury prevention in the industrial workforce.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.